TPTX

Turning Point Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD75.49

+0.09 (+0.12%)

Open

75.32

Prev. Close

75.40

Day Low

75.30

Day High

75.77

Volume

1.03M

News SentimentBullish

Articles

Avg Positive

27.2%

Avg Negative

3.6%

Avg Neutral

69.1%

News Feed

Turning Point Therapeutics Appoints Paolo Tombesi as Executive Vice President and Chief Financial Officer

Turning Point Therapeutics Granted FDA Orphan Drug Designation for TPX-0022 in Gastric Cancer

Turning Point Therapeutics Names Kumar Srinivasan as Executive Vice President, Chief Business Officer